Suzanne de Bruijn

163 The development of a genetic therapy for DFNA21 15. Lentz, J.J., Pan, B., Ponnath, A., Tran, C.M., Nist-Lund, C., Galvin, A. et al. Direct delivery of antisense oligonucleotides to the middle and inner ear improves hearing and balance in usher mice. Molecular Therapy 28 , 2662-2676 (2020). 16. Delprat, B., Boulanger, A.,Wang, J., Beaudoin, V., Guitton, M.J., Ventéo, S. et al. Downregulation of otospiralin, a novel inner ear protein, causes hair cell degeneration and deafness. Journal of Neuroscience 22 , 1718-25 (2002). 17. Pallan, P.S. & Egli, M. Insights into RNA/DNA hybrid recognition and processing by RNase H from the crystal structure of a non-specific enzyme-dsDNA complex. Cell Cycle 7 , 2562-2569 (2008). 18. Aartsma-Rus, A., van Vliet, L., Hirschi, M., Janson, A.A.M., Heemskerk, H., de Winter, C.L. et al. Guidelines for antisense oligonucleotide design and insight into splice-modulating mechanisms. Molecular Therapy 17 , 548-553 (2009). 19. Slijkerman, R., Kremer, H. & van Wijk, E. Antisense oligonucleotide design and evaluation of splice-modulating properties using cell-based assays. Methods in Molecular Biology 1828 , 519-530 (2018). 20. Zuker, M. Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Research 31 , 3406-3415 (2003). 21. Roosing, S., Lamers, I.J., de Vrieze, E., van den Born, L.I., Lambertus, S., Arts, H.H. et al. Disruption of the basal body protein POC1B results in autosomal-recessive cone-rod dystrophy. American Journal of Medical Genetics 95 , 131-142 (2014). 22. Kiełpiński, Ł.J., Hagedorn, P.H., Lindow, M. & Vinther, J. RNase H sequence preferences influence antisense oligonucleotide efficiency. Nucleic Acids Research 45 , 12932-12944 (2017). 23. Reuter, J.S. & Mathews, D.H. RNAstructure: software for RNA secondary structure prediction and analysis. BMC Bioinformatics 11 , 129 (2010). 24. Wang, B. An ASO modification that enhances nuclease resistance, lowers toxicity, and increases binding affinity - the 2'MOE analog. (Integrated DNA Technologies, 2018). 25. Rukov, J.L., Hagedorn, P.H., Høy, I.B., Feng, Y., Lindow, M. & Vinther, J. Dissecting the target specificity of RNase H recruiting oligonucleotides using massively parallel reporter analysis of short RNA motifs. Nucleic Acids Research 43 , 8476-8487 (2015). 26. Hagedorn, P.H., Hansen, B.R., Koch, T. & Lindow, M. Managing the sequence-specificity of antisense oligonucleotides in drug discovery. Nucleic Acids Research 45 , 2262-2282 (2017). 27. Tang, P.C., Hashino, E. & Nelson, R.F. Progress in modeling and targeting inner ear disorders with pluripotent stem cells. Stem Cell Reports 14 , 996-1008 (2020). 28. Dulla, K., Slijkerman, R., van Diepen, H.C., Albert, S., Dona, M., Beumer, W. et al. Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. Molecular Therapy In press (2021). 29. Lentz, J.J., Jodelka, F.M., Hinrich, A.J., McCaffrey, K.E., Farris, H.E., Spalitta, M.J. et al. Rescue of hearing and vestibular function by antisense oligonucleotides in a mouse model of human deafness. Nature Medicine 19 , 345-350 (2013). 30. de Cates, C. &Winters, R. Intratympanic steroid injection. in StatPearls (StatPearls Publishing, Treasure Island (FL), 2021).